Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
In this pilot study, we show that periprocedural administration of tirofiban during stenting of critically stenosed saphenous vein grafts, significantly reduces the occurrence of postprocedural minor myocardial necroses.
Kurowski
Volkhard
V
Medizinische Klinik II, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Toelg
Ralph
R
Jain
Deepak
D
Richter
Carsten
C
Wiegand
Uwe K H
UK
Richardt
Gert
G
Khattab
Ahmed A
AA
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000009:adverse effects* / Q000379:methods; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology / Q000628:therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000097:blood / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D010865:Pilot Projects; D012501:Saphenous Vein / Q000637:transplantation; D015607:Stents; D000077466:Tirofiban; D016896:Treatment Outcome; D020107:Troponin T / Q000097:blood*; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018608:Ultrasonography, Doppler / Q000379:methods; D018084:Ultrasonography, Interventional
D005343:Fibrinolytic Agents; D020107:Troponin T; D014443:Tyrosine; D000077466:Tirofiban